INBRAIN Neuroelectronics Completes MINIGRAPH Project, Advancing Graphene-Based Brain-Computer Interfaces and Robotic Neural Implantation INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing graphene-based brain-computer interface (BCI) therapeutics, has announced the successful completion…
Glaukos Reports Positive Three-Year Phase 3 Extension Results for Epioxa in Keratoconus Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company developing innovative therapies for glaucoma, corneal disorders…
Life Sciences BC Selects 2027 Investor Readiness Program Cohort to Support Growth of Emerging Life Sciences Companies Life Sciences BC (LSBC) has announced the companies selected to participate in its…
PureTech’s Seaport Therapeutics Doses First Patient in Phase 2a Trial of GlyphAgo for Generalized Anxiety Disorder PureTech Health plc (LSE: PRTC) announced that its Founded Entity, Seaport Therapeutics (Nasdaq: SPTX),…
FDA Approves Pfizer’s TUKYSA Regimen for First-Line Maintenance in HER2+ Metastatic Breast Cancer Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved TUKYSA® (tucatinib) in combination…
PearlDX Publishes Clinical Evidence Supporting FDA-Cleared MycoMEIA Urine Test for Invasive Aspergillosis Pearl Diagnostics, also known as PearlDX, has announced the publication of new clinical studies supporting the U.S. Food…
Medisca and EUROAPI Form Strategic Partnership to Expand API Access for Pharmaceutical Compounding Medisca and EUROAPI have entered into a strategic partnership designed to expand access to active pharmaceutical ingredients…
Bridge Neurotech Emerges from Stealth with Non-Invasive Brain-Computer Interface Vision, Partners with Butterfly Network Bridge Neurotech, a company developing a completely non-invasive brain-computer interface (BCI), has emerged from stealth with…
RoslinCT Secures Up to £7.25 Million Scottish Enterprise Grant to Accelerate Digital Transformation of Cell Therapy Manufacturing RoslinCT, a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell…
Invivoscribe Launches Complete LymphoTrack Flex Suite for NGS-Based Clonality and MRD Analysis Invivoscribe, a global provider of precision diagnostics and measurable residual disease (MRD) testing solutions, has announced the launch…
Dexcom Launches Fifth Season of Dexcom U NIL Program for College Athletes With Diabetes Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, has launched the fifth season of…
City of Hope Names Laurie Sicaeros and Melissa Childress to Lead Cancer Centers in Arizona and Atlanta City of Hope, one of the largest and most advanced cancer research and…